GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP H-1B Visa Sponsorship & Salary Data

The median H-1B salary at GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP is $103,875, based on 31 certified filings from FY 2020 to FY 2025. This is 13% lower than the national H-1B median salary of $120,000. Compensation at GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP reflects their market positioning, with entry-level roles starting around $82,930 and senior positions reaching $140,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP range from $73,000 at the 10th percentile to $140,000 at the 90th percentile, showing a $67,000 spread across experience levels and roles. The 25th percentile is $82,930 and the 75th percentile is $121,170.

Yes, GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 31 H-1B labor condition applications from FY 2020 to FY 2025, demonstrating ongoing commitment to hiring international talent. With 31 certified applications and a 0% denial rate, GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP filed 6 H-1B applications, with 6 certified and 0 denied. Over 6 years of data, GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 31 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP as a potential H-1B sponsor.

This is an excellent approval rate, indicating GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 31 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP:

The most frequently sponsored role is Principal QA Engineer with 3 filings at a median salary of $103,875. This is followed by Senior Quality Control Analyst (2 filings) and Automation Engineer I.

GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP H-1B locations:

The largest H-1B hub for GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP is Framingham, MA with 20 filings at a median salary of $105,750. The highest-paying location is Cambridge, MA at $168,210 median. Salaries range from $60,500 to $168,210 across office locations.

GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP's median H-1B salary has increased by +57% from FY 2020 ($83,000) to FY 2025 ($130,582). Tracking salary trends over time reveals how GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP.

Year-by-year breakdown:

• FY 2021: $85,966 (3 certified)
• FY 2022: $127,733 (6 certified)
• FY 2023: $103,875 (4 certified)
• FY 2024: $105,750 (2 certified)
• FY 2025: $130,582 (6 certified)

This 57% growth reflects strong compensation adjustments at GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP, keeping pace with market demands for H-1B talent.

GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP primarily files H-1B applications at Wage Level IV, accounting for 38% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP's median H-1B salary of $103,875 is 13% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP's offerings with similar companies in your field for a more accurate assessment.

GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP files 21% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 31 certified filings, GENZYME THERAPEUTIC PRODUCTS PARTNERSHIP invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.